• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Feds Announce Charges in $2 Billion Medicare-Fraud Scheme

Share:

October 1, 2019

Federal authorities on Friday charged more than 30 individuals in connection with an alleged Medicare-fraud scheme that took as much as $2 billion out of the pockets of taxpayers before it was detected.

The scheme revolved around tricking seniors into getting their cheeks swabbed for unnecessary DNA tests that would supposedly tell them whether they were genetically predisposed to serious diseases, including cancer. The defendants would then charge Medicare for the swabs. In total, they are alleged to have collected $2 billion in reimbursements, with the typical bill running between $7,000 and $12,000. The plot involved telemarketers, doctors, and a lab running the DNA tests, although many of the Medicare patients never received their test results.

“A decade ago, it would have given Medicare beneficiaries pause if someone wanted to get a swab from their cheek of their saliva,” said Shimon Richmond, the Department of Health and Human Services’ assistant inspector general for investigations. “Today people know and recognize what (genetic testing) is, and they think ‘I can get that done, and I can get it done for free and find out if I have health issues that I need to address.’”

Officials warned Medicare enrollees not to be duped by such scams, and only to have a genetic test done if their primary doctor recommends it.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: October 03, 2019

Source: National Review

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Medicare Advantage Plans Overturn 75% of Their Own Claim DenialsMedicare Advantage Plans Overturn 75% of Their Own Claim Denials
  • Apple, Cerner Call for Interoperability Rule Release ‘Without Further Delay’, Highlighting Industry RiftApple, Cerner Call for Interoperability Rule Release ‘Without Further Delay’, Highlighting Industry Rift
  • State of Connecticut Launches of Livongo for Diabetes Management Program through State Health PlanState of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan
  • HHS Clarifies HIPAA Liability Around Third-Party Health AppsHHS Clarifies HIPAA Liability Around Third-Party Health Apps
  • Platform launched to enhance China’s community-level healthcare servicesPlatform launched to enhance China’s community-level healthcare services
  • AHA Says ONC, CMS Need to ‘Rethink’ EHR Documentation RulesAHA Says ONC, CMS Need to ‘Rethink’ EHR Documentation Rules

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications